Journal of Primeasia
Multidisciplinary research and review journal | Online ISSN 3064-9870
  1. You are here:
  2. Home
  3. Journals
  4. Biological Sciences
REVIEWS   (Open Access)
Contents Vol 2 (1)

Management of COVID-19 Crisis: Bangladesh Perspectives

Suvamoy Datta1,2* , Maruf Abony1, Priyanka Dutta 3

+ Author Affiliations

Journal of Primeasia 2 (1) 1-6 https://doi.org/10.25163/primeasia.20211

Submitted: 01 November 2020 Revised: 25 December 2020  Published: 11 January 2021 

Abstract

Bangladesh has one of the world's most extensive networks of community health workers and a robust tradition of public-private collaboration during crises, underpinned by resilient communities. These strengths highlight Bangladesh's capacity to navigate the current COVID-19 crisis effectively, finding optimal solutions to ensure survival amidst the catastrophe. Globally, the COVID-19 pandemic has ravaged lives and caused widespread societal disruption, prompting closures of schools and workplaces aimed at curbing transmission and delaying the epidemic's peak. Bangladesh's strategy to combat COVID-19 cannot rely solely on governmental efforts; it necessitates unprecedented collaboration across public and private sectors, both locally and internationally. Initiatives such as the COVID-19 Action Platform by the World Economic Forum, in conjunction with the World Health Organization, have been pivotal in responding to the pandemic. Bangladesh can leverage these platforms to bolster its private sector, share its experiences in managing COVID-19, and enhance economic resilience. Data from the Institute of Epidemiology, Disease Control, and Research highlight that the majority (62%) of COVID-19 cases in Bangladesh have occurred among individuals aged 21-50. Notably, those aged 31-40 account for the largest segment (23%) of infections, followed by those aged 21-30 (20%), and 41-50 (19%). Patients aged 51-60 constitute 15% of cases, while those over 60 represent 13%. Adolescents (ages 11-20) and children (under 10) comprise 7% and 3% of cases, respectively. This demographic profile aligns with trends observed in neighboring India but differs from harder-hit countries like the USA, China, and Spain.

Keywords:  Bangladesh, COVID-19, Community health workers, Pandemic response, Public-private cooperation.

References

American College of Radiology. (2020, March 28). Recommendations for chest radiography and CT for suspected COVID-19 infection. https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection

Brueck, H. (2020). There’s only one way to know if you have the coronavirus, and it involves machines full of spit and mucus. Business Insider, 28(3), 31-46.

Centers for Disease Control and Prevention. (2020, February 1). Clarifications about retirement CDC 2019 novel coronavirus. https://www.cdc.gov/locs/2021/08-02-2021-lab-alert-clarifications_about_retirement_cdc_2019_novel_coronavirus_1.html

Centers for Disease Control and Prevention. (2020, February 10). How to protect yourself & others. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html

Centers for Disease Control and Prevention. (2020, February 11). Symptoms of coronavirus. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html

Centers for Disease Control and Prevention. (2020, January 30). 2019 Novel Coronavirus situation summary. https://www.cdc.gov/library/researchguides/2019NovelCoronavirus

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., ... & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395, 507-513. https://doi.org/10.1016/S0140-6736(20)30211-7

Cohen, J., & Normile, D. (2020). New SARS-like virus in China triggers alarm. Science, 367(6475), 347-348. https://doi.org/10.1126/science.367.6475.347

Dhaka Tribune. (2020, March 30). COVID-19 pandemic: Testing remains low despite having enough kits in stock. https://archive.dhakatribune.com/bangladesh/2020/03/29/covid-19-pandemic-testing-remains-low-despite-having-enough-kits-in-stock

Elsevier. (2020, January 31). Coronavirus information center. https://www.elsevier.com/connect/coronavirus-information-center

HeadTopics. (2020, March 20). My hand-washing song: Readers offer lyrics for a 20-second scrub. HeadTopics. https://headtopics.com/us/my-hand-washing-song-readers-offer-lyrics-for-a-20-second-scrub-11922960

Hopkins, C. (2020, March 28). Loss of sense of smell as marker of COVID-19 infection. Ear, Nose and Throat Surgery Body of United Kingdom. https://www.entuk.org/loss-sense-smell-marker-covid-19-infection

Hui, D. S., Azhar, E. I., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., ... & Memish, Z. A. (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases, 91, 264-266. https://doi.org/10.1016/j.ijid.2020.01.009

Iacobucci, G. (2020). Sixty seconds on... anosmia. The BMJ, 368, m1202. https://doi.org/10.1136/bmj.m1202

Institute of Epidemiology, Disease Control and Research. (2020, March 27). COVID-19 situation updates. https://iedcr.gov.bd/covid-19/covid-19-situation-updates

Moniruzzaman, M., Hossain, M. U., Islam, M. N., Rahman, M. H., Ahmed, I., Rahman, T. A., ... & Hoque, A. S. M. S. (2020). Coding-complete genome sequence of SARS-CoV-2 isolate from Bangladesh by Sanger sequencing. Microbiology Resource Announcements, 9(28), e00626-20. https://doi.org/10.1128/MRA.00626-20

New Age Bangladesh. (2020, March 30). Six die with coronavirus symptoms; no new case reported in Bangladesh. https://www.newagebd.net/article/103364/six-die-with-coronavirus-symptoms-no-new-case-reported-in-bangladesh

New Age Bangladesh. (2020, March 30). Young working-age people most infected in Bangladesh. https://www.newagebd.net/article/104307/young-working-age-people-most-infected-in-bangladesh

Pang, J., Wang, M. X., Ang, I. Y. H., Tan, S. H. X., Lewis, R. F., Chen, J. I.-P., ... & Yap, R. K. S. (2020). Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): A systematic review. Journal of Clinical Medicine, 9(3), 623. https://doi.org/10.3390/jcm9030623

Reuters. (2020, March 27). Massive Bangladesh coronavirus prayer gathering sparks outcry. https://www.reuters.com/article/us-health-coronavirus-bangladesh-idUSKBN20V0FS

U.S. Food and Drug Administration. (2020, March 22). Coronavirus (COVID-19) update: FDA issues first emergency use authorization for point-of-care diagnostic. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-first-emergency-use-authorization-point-care-diagnostic

Vienna BioCenter. (2020, February 1). Curetis company Ares Genetics and BGI Group to offer sequencing and PCR-based coronavirus 2019-nCoV testing in Europe. Vienna BioCenter. https://www.viennabiocenter.org/about/news/curetis-company-ares-genetics-and-bgi-group-to-offer-sequencing-and-pcrbased-coronavirus-2019-ncov-testing-in-europe/

Vogel, G. (2020). New blood tests for antibodies could show true scale of coronavirus pandemic. Science. https://doi.org/10.1126/science.covidwho-9938

Wei, X.-S., Wang, X., Niu, Y.-R., Ye, L.-L., Peng, W.-B., Wang, Z.-H., ... & He, J.-F. (2020). Clinical characteristics of SARS-CoV-2 infected pneumonia with diarrhea. The Lancet Respiratory Medicine, 1-24. https://doi.org/10.1016/S2213-2600(20)30126-3

World Health Organization. (2020, February 10). Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public#:~:text=Keep%20physical%20distance%20of%20at%20least%20one%20meter%20from%20others.

World Health Organization. (2020, February 28). Naming the coronavirus disease (COVID-2019) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

World Health Organization. (2020, January 17). Laboratory testing of 2019 novel coronavirus (2019-nCoV) in suspected human cases: Interim guidance. https://www.who.int/publications/i/item/10665-331501

World Health Organization. (2020, January 27). Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019

World Health Organization. (2020, March 11). WHO Director-General's opening remarks at the media briefing on COVID-19. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

World Health Organization. (2020, March 13). Laboratory testing of 2019 novel coronavirus (2019-nCoV) in suspected human cases: Interim guidance. https://www.who.int/publications/i/item/10665-331501

World Health Organization. (2020, March 15). Novel coronavirus (2019-nCoV). https://www.who.int/emergencies/diseases/novel-coronavirus-2019

World Health Organization. (2020, March 15). WHO Director-General's statement on IHR Emergency Committee on novel coronavirus (2019-nCoV). https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus-(2019-ncov)

Worldometer. (2020, April 2). COVID-19 coronavirus pandemic. https://www.worldometers.info/coronavirus/

Yahoo News. (2020, March 30). Massive Bangladesh coronavirus prayer gathering sparks outcry. https://news.yahoo.com/massive-bangladesh-coronavirus-prayer-gathering-sparks-outcry-193538973.html

Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020). Base estructural para el reconocimiento de SARS-CoV-2 por la enzima convertidora de angiotensina 2 (ACE2) humana completa. Science, 367, 1444-1448. https://doi.org/10.1126/science.abb2762

Zhou, C., Gao, C., Xie, Y., & Xu, M. (2020). COVID-19 with spontaneous pneumomediastinum. The Lancet Infectious Diseases, 20(4), 510. https://doi.org/10.1016/S1473-3099(20)30266-2

PDF
Abstract
Export Citation

View Dimensions


View Plumx


View Altmetric




Save
0
Citation
256
View

Share